- Home
- PRPL vs HLVX Comparison
PRPL vs HLVX Comparison
Compare PRPL & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- HLVX
- Stock Information
- Founded
- PRPL 2010
- HLVX 2020
- Country
- PRPL United States
- HLVX United States
- Employees
- PRPL N/A
- HLVX N/A
- Industry
- PRPL Home Furnishings
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- PRPL Consumer Discretionary
- HLVX Health Care
- Exchange
- PRPL Nasdaq
- HLVX Nasdaq
- Market Cap
- PRPL 125.6M
- HLVX 104.3M
- IPO Year
- PRPL N/A
- HLVX 2022
- Fundamental
- Price
- PRPL $1.03
- HLVX $2.09
- Analyst Decision
- PRPL Hold
- HLVX Hold
- Analyst Count
- PRPL 1
- HLVX 1
- Target Price
- PRPL $1.00
- HLVX $2.00
- AVG Volume (30 Days)
- PRPL 621.6K
- HLVX 824.4K
- Earning Date
- PRPL 11-03-2025
- HLVX 11-06-2025
- Dividend Yield
- PRPL N/A
- HLVX N/A
- EPS Growth
- PRPL N/A
- HLVX N/A
- EPS
- PRPL N/A
- HLVX N/A
- Revenue
- PRPL $456,844,000.00
- HLVX N/A
- Revenue This Year
- PRPL N/A
- HLVX N/A
- Revenue Next Year
- PRPL $11.87
- HLVX N/A
- P/E Ratio
- PRPL N/A
- HLVX N/A
- Revenue Growth
- PRPL N/A
- HLVX N/A
- 52 Week Low
- PRPL $0.56
- HLVX $1.34
- 52 Week High
- PRPL $1.29
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- PRPL 49.34
- HLVX 51.67
- Support Level
- PRPL $1.01
- HLVX $2.07
- Resistance Level
- PRPL $1.11
- HLVX $2.11
- Average True Range (ATR)
- PRPL 0.07
- HLVX 0.02
- MACD
- PRPL -0.02
- HLVX -0.00
- Stochastic Oscillator
- PRPL 8.00
- HLVX 36.36
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.